Find insight on Samsung Biologics, China biotech companies and more in the latest Market Talks covering Health Care.

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced the launch of Samsung Organoids – advanced drug screening services to ...

Samsung Biologics has also established sales offices in New Jersey, Boston, and earlier this year in Tokyo, Japan, to expand its CDMO orders. CEO John Lim predicted that the CDMO market will ...

Samsung Biologics (KRX: 207940.KS) is a leading contract development and manufacturing organization (CDMO), offering end-to-end integrated services that range from late discovery to commercial ...

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced the launch of Samsung Organoids – advanced drug screening services to support ...

The Securities and Futures Commission later concluded that Samsung Biologics had conducted about 4.5 trillion won worth of accounting fraud, by changing the classification of Samsung Bioepis from ...

Samsung Biologics is also exploring partnerships with overseas hospitals to broaden its patient-derived organoid bank and is considering future data licensing models. While its organoid unit may start ...

Samsung Biologics Co Ltd stock price live, this page displays KS 207940 stock exchange data. View the 207940 premarket stock price ahead of the market session or assess the after hours quote.

Samsung Organoids to provide data-driven analysis of candidate moleculesSamsung Biologics expands service scope to include preclinical researchINCHEON, South Korea, June 15, 2025 /PRNewswire ...

Samsung Biologics said Monday it launched a drug candidate screening service to support clients in drug discovery and development, expanding its portfolio beyond contract development and ...

Samsung Biologics announced last month that it will spin off its wholly-owned biosimilar subsidiary Bioepis as an independent firm, in order to address clients’ concerns for potential conflict ...

Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. The company ...